Related Experiment Video
Updated: Jul 7, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
Cytokines and myocardial dysfunction: state of the art
1Weill Cornell Faculty of Medicine, Doha, Qatar.
Insights
Cytokines play a role in myocardial dysfunction. Current anticytokine treatments are not recommended for advanced heart failure, necessitating further research for optimal cytokine and immunomodulation therapy timing.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Myocardial dysfunction is linked to inflammation and altered cytokine levels.
- Cytokines are key mediators in cardiovascular disease processes.
Purpose of the Study:
- To elucidate the role of cytokines in the development and treatment of myocardial dysfunction.
- To review current understanding of cytokine involvement in heart failure.
Main Methods:
- Systematic literature review of Medline, Scopus, Cochrane Database, and EBSCO Host.
- Analysis of published articles concerning heart failure and cytokine modulation.
Main Results:
- Proinflammatory cytokines require further investigation for diagnostic and therapeutic applications.
- Anticytokine therapy is not advised for patients with advanced heart failure currently.
Conclusions:
- Further research is essential to determine the optimal timing for cytokine and immunomodulation therapies.
- Understanding cytokine roles is crucial for future heart failure management strategies.
Background:
Myocardial dysfunction has been associated with inflammation and cytokine modulation.
Objectives:
The study objective was to understand the role of cytokines in the pathophysiology and management of myocardial dysfunction.
Methods:
Heart failure has been revisited with revision of the pertinent published articles in the Medline, Scopus, Cochrane Database of Systematic Reviews, and EBSCO Host research.
Results:
For the proinflammatory cytokines, illumination of this important point requires further diagnostic and therapeutic investigations. Data on chronic heart failure are not so reassuring; therefore, patients with advanced heart failure should not be treated with anticytokines at this time.
Conclusion:
Further studies are warranted to pave the way for introducing cytokine and immunomodulation therapy at the optimal and appropriate time.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Pathophysiology of Cardiac Performance
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

